Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Methods and compositions for the treatment of pancreatitis

a technology for pancreatitis and compositions, applied in drug compositions, fusions for specific cell targeting, antibody medical ingredients, etc., can solve problems such as the destruction of pancreatic tissue, and achieve the effects of preventing the formation of a core complex, and preventing or reducing the extent of vesicle fusion

Inactive Publication Date: 2005-05-05
ALLERGAN INC
View PDF2 Cites 28 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention relates to methods and compositions for treating acute pancreatitis. The condition is caused by the defective secretion of zymogen granules by acinar cells, which results in the destruction of pancreatic tissue. The invention provides a therapeutic agent that contains a chimeric protein with the ability to cleave specific proteins involved in the disease process. The chimeric protein also has the ability to bind to a specific cell surface receptor, allowing for targeted delivery to pancreatic cells. The therapeutic agent can be administered through various routes, including intravenous infusion. The invention also provides a method for treating acute pancreatitis by administering the therapeutic agent to a patient. The therapeutic agent can also contain other therapeutic agents, such as hormones, nucleic acids, or toxins, which can further enhance the effectiveness of the treatment.

Problems solved by technology

This condition is largely due to the defective secretion of zymogen granules by acinar cells, and by the premature co-mingling of the secreted zymogens with lysosomal hydrolysates capable of activating trypsin, thereby triggering the protease activation cascade and resulting in the destruction of pancreatic tissue.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0086] An agent for the treatment of acute pancreatitis is constructed as follows.

[0087] A culture of Clostridium botulinum is permitted to grown to confluence. The cells are then lysed and total RNA is extracted according to conventional methods and in the presence of an RNAse inhibitor. The RNA preparation is then passed over a oligo(dT) cellulose column, the polyadenylated messenger RNA is permitted to bind, and the column is washed with 5-10 column volumes of 20 mM Tris pH 7.6, 0.5 M NaCl, 1 mM EDTA (ethylenediamine tetraacetic acid), 0.1% (w / v)SDS (sodium dodecyl sulfate). Polyadenylated RNA is then eluted with 2-3 column volumes of STE (10 mM Tris (pH 7.6), 1 mM EDTA, 0.05% (w / v) SDS). The pooled MRNA is then precipitated in 2 volumes of ice cold ethanol, pelleted in a centrifuge at 10,000×g for 15 minutes, then redissolved in a small volume of STE.

[0088] The BoNT / A MRNA is used as a template for DNA synthesis using Moloney murine leukemia virus reverse transcriptase (MMLV-R...

example 2

Method of Treating a Patient Suffering from Acute Pancreatitis

[0090] A therapeutically effective amount of the BoNT / AL-HN-γ-CCK agent constructed and purified as set forth in Example 1 is formulated in an acceptable infusion solution. Properties of pharmacologically acceptable infusion solutions, including proper electrolyte balance, are well known in the art. This solution is provided intravenously to a patient suffering from acute pancreatitis on a single day over a period of one to two hours. Additionally, the patient is fed intravenously on a diet low in complex carbohydrates, complex fats and proteins.

[0091] At the beginning of treatment, the patient's pancreas shows signs of autodigestion, as measured by blood amylase levels. After the treatment regimen, autodigestion has ceased, and the patient's pancreas has stabilized.

example 3

Alternative Treatment Method

[0092] In this example, a patient suffering from acute pancreatitis is treated as in Example 2, with, the therapeutic agent given continuously over a period of two weeks. After the treatment regimen, autodigestion has ceased, and the patient's pancreas has stabilized.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
affinityaaaaaaaaaa
compositionaaaaaaaaaa
alkaline optimal environmentaaaaaaaaaa
Login to View More

Abstract

Methods and compositions for the treatment of acute pancreatitis in a mammal. Particular compositions comprise a binding element, a translocation element, and a therapeutic element able to prevent accumulation of digestive enzymes within the pancreas.

Description

[0001] This application is a continuation-in-part of application Ser. No. 09 / 288,326, filed Apr. 8, 1999.FIELD OF THE INVENTION [0002] The present invention includes methods and compositions for the treatment of acute pancreatitis. In a preferred embodiment the invention concerns the use of agents to reduce or prevent the secretion of pancreatic digestive enzymes within the pancreas. Such agents are targeted to pancreatic cells, and serve to prevent the exocytotic fusion of vesicles containing these enzymes with the plasma membrane. The invention is also concerned with methods of treating a mammal suffering from pancreatitis through the administration of such agents. BACKGROUND OF THE INVENTION [0003] Pancreatitis is a serious medical condition involving an inflammation of the pancreas. In acute or chronic pancreatitis the inflammation manifests itself in the release and activation of pancreatic enzymes within the organ itself, leading to autodigestion. In many cases of acute pancre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K47/48
CPCA61K47/48261C07K14/33C07K2319/33C07K2319/00C07K2317/53A61K47/6415A61P1/18
Inventor STEWARD, LANCESACHS, GEORGEAOKI, KEI
Owner ALLERGAN INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com